Data Usage Among other things, our MeDIC provides data according to the specifications and regulations of the MII . All university hospitals connected to the MII infrastructure have agreed on a common

The Use Case PM4Onco Oncology The use case PM4Onco ( P ersonalised M edicine for ( 4 ) Onco logy) aims to advance personalised medicine in cancer treatment. For this purpose, a permanent infrastructur

The Use Case CALM-QE Pediatric Pulmology Chronic obstructive pulmonary disease (COPD) and bronchial asthma (BA) are the most common non-communicable lung diseases with significant socioeconomic impact

The Use Case RISK PRINCIPE Infectiology Nosocomial infections - i.e. infections acquired in a hospital or a care facility - represent a great burden for the patients affected, the health care staff an

2. Funding period (NUM 2.0): 2022–2025 NUM-Projects of the 2. funding period at the MHH AKTIN 2.0 / AKTIN - Notaufnahmeregister Project leader: Dr. Torben Brod, MD Department / Institute: Emergency De

1. Funding period (NUM 1.0): 2020–2021 NUM-Projects of 1. funding period at the MHH B-FAST / National Research Network "Applied Surveillance and Testing" Project leader: Prof. Dr. Reinhold Förster Dep

FOR 2799 Receiving and Translating Signals via the γδ T Cell Receptor Speaker: Professor Dr. Immo Prinz Hannover Medical School Institute of Immunology Carl-Neuberg-Straße 1 30625 Hannover Phone: +49

Teaching Lectures / Practical Courses Immunology for B.Sc. students (biology and biochemistry) as well as M.Sc. students (biomedicine and biochemistry) Special Immunology for M.Sc. students Four-week